Academic literature on the topic 'KIT tyrosine kinase'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'KIT tyrosine kinase.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "KIT tyrosine kinase"
Heinrich, Michael C., Diana J. Griffith, Brian J. Druker, Cecily L. Wait, Kristen A. Ott, and Amy J. Zigler. "Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor." Blood 96, no. 3 (August 1, 2000): 925–32. http://dx.doi.org/10.1182/blood.v96.3.925.
Full textHeinrich, Michael C., Diana J. Griffith, Brian J. Druker, Cecily L. Wait, Kristen A. Ott, and Amy J. Zigler. "Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor." Blood 96, no. 3 (August 1, 2000): 925–32. http://dx.doi.org/10.1182/blood.v96.3.925.015k50_925_932.
Full textLedoux, Julie, and Luba Tchertanov. "Does Generic Cyclic Kinase Insert Domain of Receptor Tyrosine Kinase KIT Clone Its Native Homologue?" International Journal of Molecular Sciences 23, no. 21 (October 25, 2022): 12898. http://dx.doi.org/10.3390/ijms232112898.
Full textMarmigère, Frédéric, Frédérique Scamps, and Jean Valmier. "Le récepteur tyrosine kinase c-Kit." médecine/sciences 24, no. 5 (May 2008): 464–66. http://dx.doi.org/10.1051/medsci/2008245464.
Full textBandi, Srinivasa Rao, Christian Brandts, Marion Rensinghoff, Rebekka Grundler, Lara Tickenbrock, Gabriele Köhler, Justus Duyster, et al. "E3 ligase–defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease." Blood 114, no. 19 (November 5, 2009): 4197–208. http://dx.doi.org/10.1182/blood-2008-12-190934.
Full textKinashi, T., JA Escobedo, LT Williams, K. Takatsu, and TA Springer. "Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-gamma 1 pathways." Blood 86, no. 6 (September 15, 1995): 2086–90. http://dx.doi.org/10.1182/blood.v86.6.2086.bloodjournal8662086.
Full textSun, Jianmin, Malin Pedersen, and Lars Rönnstrand. "The D816V Mutation of C-Kit Circumvents a Requirement for Src Family Kinases in C-Kit Mediated Signal Tranduction and Transformation." Blood 112, no. 11 (November 16, 2008): 2849. http://dx.doi.org/10.1182/blood.v112.11.2849.2849.
Full textPan, Jingxuan, Hagop Kantarjian, Jorge Cortes, Francis Giles, and Srdan Verstovsek. "Effect of Tyrosine Kinase Inhibitor INNO-406 on Human Mast Cells Bearing Mutated c-KIT Tyrosine Kinase." Blood 108, no. 11 (November 16, 2006): 4890. http://dx.doi.org/10.1182/blood.v108.11.4890.4890.
Full textKornbluth, S., K. E. Paulson, and H. Hanafusa. "Novel tyrosine kinase identified by phosphotyrosine antibody screening of cDNA libraries." Molecular and Cellular Biology 8, no. 12 (December 1988): 5541–44. http://dx.doi.org/10.1128/mcb.8.12.5541-5544.1988.
Full textKornbluth, S., K. E. Paulson, and H. Hanafusa. "Novel tyrosine kinase identified by phosphotyrosine antibody screening of cDNA libraries." Molecular and Cellular Biology 8, no. 12 (December 1988): 5541–44. http://dx.doi.org/10.1128/mcb.8.12.5541.
Full textDissertations / Theses on the topic "KIT tyrosine kinase"
Edling, Charlotte. "Receptor tyrosine kinase c-Kit signalling in hematopoietic progenitor cells." Doctoral thesis, Umeå : Umeå University, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-888.
Full textRead, Stuart Hamilton. "Production and function of a soluble c-Kit molecule." Title page, abstract and contents only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phr2845.pdf.
Full textShulman, Johanna. "Biochemical analysis of activating mutations of the kit receptor tyrosine kinase." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape10/PQDD_0003/MQ40794.pdf.
Full textRosnet, Olivier. "Caractérisation d'un recepteur à tyrosine kinase apparenté à KIT et FMS." Aix-Marseille 2, 1993. http://www.theses.fr/1993AIX22045.
Full textLermet, Anne. "Synthèse d'inhibiteurs de la protéine à activité tyrosine kinase c-kit de type sauvage et muté." Lyon 1, 2006. http://www.theses.fr/2006LYO10026.
Full textCambareri, Antony Charles. "Molecular and cellular studies examining the biological significance of different isoforms of the receptor tyrosine kinase, c-Kit /." Title page, table of contents and abstract only, 2004. http://web4.library.adelaide.edu.au/theses/09PH/09phc174.pdf.
Full textBaker, Clare V. H. "XKrk1, a c-kit-related receptor tyrosine kinase expressed in Xenopus embryos." Thesis, University of Cambridge, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.338070.
Full textAndré, Catherine. "Les oncogenes c-kit et c-fms : recepteurs a activite tyrosine kinase." Paris 7, 1992. http://www.theses.fr/1992PA077214.
Full textAn, Ningfei, Bo Cen, Houjian Cai, Jin H. Song, Andrew Kraft, and Yubin Kang. "Pim1 kinase regulates c-Kit gene translation." BIOMED CENTRAL LTD, 2016. http://hdl.handle.net/10150/622957.
Full textLarrue, Clément. "Régulation de l'expression protéique des récepteurs à activité tyrosine kinase FLT3 et KIT dans les leucémies aigües myéloïdes." Thesis, Toulouse 3, 2015. http://www.theses.fr/2015TOU30195.
Full textFLT3-ITD and KITD816V mutations are recurrently found in acute myeloid leukemia, where they are associated with a poor prognosis. These two Tyrosine Kinase Receptors (TKR) are involved in leukemogenesis, regulating proliferation, survival and cell differentiation. The aim of this thesis was to study the regulation of FLT3 protein expression in response to proteasome inhibitors, the role of autophagy in KITD816V-driven AML and the impact of 2-deoxy-D-glucose (2-DG) on the intracellular localization of TKRs. Our studies investigated three original ways to target cells bearing FLT3-ITD or oncogenic KIT mutations playing on their degradation, intracellular localization and autophagy
Books on the topic "KIT tyrosine kinase"
Shulman, Johanna. Biochemical analysis of activating mutations of the Kit receptor tyrosine kinase. Ottawa: National Library of Canada, 1998.
Find full textLam, Lily Po Yee. A transforming mutation induces dimerization and enhances activity of the c-kit soluble tyrosine kinase domain. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.
Find full textKlüppel, Michael. Analysis of regulatory W mutations and the function of the kit receptor tyrosine kinase in the intestine. 1998.
Find full textBook chapters on the topic "KIT tyrosine kinase"
Salajegheh, Ali. "C-KIT: Tyrosine Kinase Receptors with Potential to Initiate Angiogenesis." In Angiogenesis in Health, Disease and Malignancy, 33–36. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-28140-7_6.
Full textLedoux, Julie, and Luba Tchertanov. "Receptor Tyrosine Kinase KIT: A New Look for an Old Receptor." In Bioinformatics and Biomedical Engineering, 133–37. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-07802-6_11.
Full textRay-Coquard, I., T. Bachelot, J. P. Guastalla, and J. Y. Blay. "Les autres inhibiteurs tyrosine kinase de KIT ou de la voie AKT." In Les thérapies ciblées, 117–30. Paris: Springer Paris, 2008. http://dx.doi.org/10.1007/978-2-287-36008-4_8.
Full textZschäbitz, Stefanie, and Carsten Grüllich. "Lenvantinib: A Tyrosine Kinase Inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, KIT and RET." In Recent Results in Cancer Research, 187–98. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-91442-8_13.
Full textWalker, Christoph, David Rodman, and Trevor T. Hansel. "Therapy directed against c-kit (CD117) and PDGF transmembrane receptor tyrosine kinases." In New Drugs and Targets for Asthma and COPD, 279–82. Basel: KARGER, 2010. http://dx.doi.org/10.1159/000320831.
Full textHayman, Suzanne R., and Judith E. Karp. "Tyrosine Kinase Inhibitors: Targets Other Than FLT3, BCR-ABL, and c-KIT." In Innovative Leukemia and Lymphoma Therapy, 429–47. CRC Press, 2019. http://dx.doi.org/10.1201/9780429114670-18.
Full textChoi, Haesun. "Gastrointestinal stromal tumours." In Imaging for Clinical Oncology, 137–47. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198818502.003.0011.
Full textReiter, Andreas, and Nicholas C. P. Cross. "Eosinophilia-associated myeloproliferative neoplasms." In Oxford Specialist Handbook: Myeloproliferative Neoplasms, 204–21. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198744214.003.0013.
Full textConference papers on the topic "KIT tyrosine kinase"
Guntur, Vamsi P., Tekla M. Lee-Fowler, John Dodam, Leah A. Cohn, Amy E. DeClue, and Carol R. Reinero. "The Effect Of Masitinib, A C-kit/PDGF Receptor Tyrosine Kinase Inhibitor, On IgE And Ventilator Parameters In Experimental Feline Asthma." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4076.
Full textTetsu, Osamu, Janyaporn Phuchareon, Annie Chou, Darren P. Cox, David W. Eisele, and Richard CK Jordan. "Abstract 351: Mutations of genes in the c-Kit receptor tyrosine kinase signaling pathway are inactive in adenoid cystic carcinoma of the salivary glands: Implications for c-Kit targeted therapy." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-351.
Full textAgarwal, Shruti, Julhash U. Kazi, Sofie Mohlin, Sven Påhlman, and Lars Rönnstrand. "Abstract 128: Tyrosine 823 in the activation loop of c-Kit regulates the transforming capacity of the oncogenic mutant D816V and its sensitivity to kinase inhibitors." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-128.
Full textJeffers, Michael, Henrik Seidel, Susanne Schwenke, Joachim Reischl, Mark Rutstein, Christian Kappeler, Iris Kuss, and Michael Teufel. "Abstract 929: Tumor genotyping in the phase III GRID study of regorafenib vs placebo in tyrosine kinase inhibitor (TKI)-refractory GIST: Detection of KIT mutations in circulating tumor DNA comparing digital PCR and massive parallel sequencing." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-929.
Full text